Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
304,000
-
Share change
-
-77,688
-
Total reported value
-
$150,000
-
Price per share
-
$0.4970
-
Number of holders
-
7
-
Value change
-
-$41,945
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2018
As of 30 Jun 2018 IGC Pharma, Inc. - COM NEW (IGC) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 304,000 shares of stock of the company.
Largest 7 holders included CITADEL ADVISORS LLC, Creative Planning, SUNTRUST BANKS INC, Virtu Financial LLC, Geneos Wealth Management Inc., UBS Group AG, and ROYAL BANK OF CANADA.
This table shows 7 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.